Chien‐Yi Hsu

2.2k total citations
79 papers, 1.7k citations indexed

About

Chien‐Yi Hsu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Chien‐Yi Hsu has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Chien‐Yi Hsu's work include Heart Failure Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiac pacing and defibrillation studies (9 papers). Chien‐Yi Hsu is often cited by papers focused on Heart Failure Treatment and Management (14 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiac pacing and defibrillation studies (9 papers). Chien‐Yi Hsu collaborates with scholars based in Taiwan, United States and Brazil. Chien‐Yi Hsu's co-authors include Po‐Hsun Huang, Shing‐Jong Lin, Jaw‐Wen Chen, Chia-Hung Chiang, Hsin‐Bang Leu, Chun Chin Chang, Tzeng‐Ji Chen, Yu‐Wen Su, Wan‐Leong Chan and Yung‐Tai Chen and has published in prestigious journals such as Circulation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Chien‐Yi Hsu

74 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien‐Yi Hsu Taiwan 22 513 403 311 305 212 79 1.7k
Hsin-Bang Leu Taiwan 27 604 1.2× 449 1.1× 283 0.9× 333 1.1× 177 0.8× 54 1.8k
Qin Luo China 21 301 0.6× 394 1.0× 173 0.6× 226 0.7× 271 1.3× 94 1.6k
En Yin Lai China 26 422 0.8× 559 1.4× 218 0.7× 591 1.9× 188 0.9× 69 1.7k
Chia‐Min Chung Taiwan 22 300 0.6× 305 0.8× 199 0.6× 268 0.9× 133 0.6× 68 1.5k
Marcus Baumann Germany 26 696 1.4× 501 1.2× 269 0.9× 304 1.0× 225 1.1× 94 2.1k
David Sanz‐Rosa Spain 22 531 1.0× 336 0.8× 276 0.9× 236 0.8× 237 1.1× 79 1.4k
Riyaz S. Patel United States 16 547 1.1× 320 0.8× 202 0.6× 149 0.5× 104 0.5× 29 1.4k
Ivonne Hernandez Schulman United States 30 732 1.4× 645 1.6× 521 1.7× 471 1.5× 521 2.5× 75 2.3k
Domenico Cozzolino Italy 23 361 0.7× 413 1.0× 283 0.9× 218 0.7× 439 2.1× 71 1.6k
Christian Werner Germany 26 677 1.3× 832 2.1× 521 1.7× 689 2.3× 191 0.9× 74 2.5k

Countries citing papers authored by Chien‐Yi Hsu

Since Specialization
Citations

This map shows the geographic impact of Chien‐Yi Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Yi Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Yi Hsu more than expected).

Fields of papers citing papers by Chien‐Yi Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Yi Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Yi Hsu. The network helps show where Chien‐Yi Hsu may publish in the future.

Co-authorship network of co-authors of Chien‐Yi Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Yi Hsu. A scholar is included among the top collaborators of Chien‐Yi Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Yi Hsu. Chien‐Yi Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Haojie, Xinyu Zhang, Chien‐Yi Hsu, et al.. (2025). Optineurin Cooperates With NRF2 to Regulate Tooth Root Morphogenesis by Controlling Mitochondrial Dynamics and Apoptosis. Cell Proliferation. 58(5). e13799–e13799.
3.
Lin, Yi, Chien‐Yi Hsu, Lingyun Cheng, et al.. (2025). Propafenone‐ vs . amiodarone‐associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure. British Journal of Clinical Pharmacology. 91(9). 2567–2575.
5.
Hsu, Chien‐Yi, Fa‐Po Chung, Chieh‐Ju Chao, et al.. (2024). Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study. Mayo Clinic Proceedings. 99(6). 940–952. 2 indexed citations
6.
Liao, Chia‐Te, et al.. (2024). Bridging the STRONG Gap: Call to Optimize Heart Failure Treatment After Hospitalization in Women and Men in Taiwan. The American Journal of Cardiology. 223. 52–57. 1 indexed citations
7.
Sung, Kuo‐Tzu, Hung‐Yu Chang, Wen‐Hung Huang, et al.. (2023). Penalized Model‐Based Unsupervised Phenomapping Unravels Distinctive HFrEF Phenotypes With Improved Outcomes Discrimination From Sacubitril/Valsartan Treatment Independent of MAGGIC Score. Journal of the American Heart Association. 12(18). e028860–e028860. 3 indexed citations
8.
Chen, Hsiu‐Mei, Yi‐Hsuan Tsai, Chien‐Yi Hsu, et al.. (2023). Peptide-Coated Bacteriorhodopsin-Based Photoelectric Biosensor for Detecting Rheumatoid Arthritis. Biosensors. 13(10). 929–929. 5 indexed citations
9.
Huang, Jin‐Long, Ying‐Hsiang Lee, Chien‐Yi Hsu, et al.. (2022). Clinical Impacts of Sacubitril/Valsartan on Patients Eligible for Cardiac Resynchronization Therapy. ESC Heart Failure. 9(6). 3825–3835. 12 indexed citations
11.
Liao, Chia‐Te, Jin‐Long Huang, Fa‐Po Chung, et al.. (2021). The Association Between Ivabradine and Adverse Cardiovascular Events in Acute Decompensated HFrEF Patients. ESC Heart Failure. 8(5). 4199–4210. 6 indexed citations
12.
Hsu, Chien‐Yi, Li-Kuo Liu, Yi-Lin Tsai, et al.. (2021). The association between serum activin A levels and albuminuria among community-dwelling middle-aged and older adults in Taiwan. Scientific Reports. 11(1). 20032–20032. 2 indexed citations
13.
Vo, Thi Thuy Tien, Chien‐Yi Hsu, Yuh‐Lien Chen, et al.. (2021). Carbon Monoxide‐Releasing Molecule‐2 Ameliorates Particulate Matter‐Induced Aorta Inflammation via Toll‐Like Receptor/NADPH Oxidase/ROS/NF‐κB/IL‐6 Inhibition. Oxidative Medicine and Cellular Longevity. 2021(1). 2855042–2855042. 9 indexed citations
14.
Hsu, Chien‐Yi, et al.. (2021). Assessing the facilities and healthcare services for heart failure: Taiwan versus European countries. Journal of the Formosan Medical Association. 121(1). 258–268. 5 indexed citations
15.
Hsu, Chien‐Yi, Ruey‐Hsing Chou, Chin‐Chou Huang, et al.. (2017). Association between echocardiographic epicardial fat thickness and circulating endothelial progenitor cell level in patients with stable angina pectoris. Clinical Cardiology. 40(9). 697–703. 6 indexed citations
16.
Kuo, Chin‐Sung, Yung‐Tai Chen, Chien‐Yi Hsu, et al.. (2017). The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan. BMJ Open. 7(8). e016179–e016179. 13 indexed citations
17.
Hsu, Chien‐Yi, Yung‐Tai Chen, Yu‐Wen Su, et al.. (2017). Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease. The Journal of Clinical Endocrinology & Metabolism. 102(7). 2373–2381. 60 indexed citations
18.
Chang, Chun Chin, Yung‐Tai Chen, Chien‐Yi Hsu, et al.. (2016). Dipeptidyl Peptidase-4 Inhibitors, Peripheral Arterial Disease, and Lower Extremity Amputation Risk in Diabetic Patients. The American Journal of Medicine. 130(3). 348–355. 26 indexed citations
19.
Hsu, Chien‐Yi, Yung‐Tai Chen, Mu‐Hong Chen, et al.. (2015). The Association Between Insomnia and Increased Future Cardiovascular Events. Psychosomatic Medicine. 77(7). 743–751. 81 indexed citations
20.
Chiang, Chia-Hung, Chia‐Jen Liu, Ping‐Jen Chen, et al.. (2014). Primary Sjögren’s syndrome and risk of ischemic stroke: a nationwide study. Clinical Rheumatology. 33(7). 931–937. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026